Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PI 18:3_22:6)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003645 AN005985 Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer Cultured cells Human Cancer Universidad Francisco de Vitoria - Hospital 12 de Octubre LC-MS
ST002398 AN003905 Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue Muscle Zebrafish Myopathy University of North Carolina at Chapel Hill LC-MS
ST001687 AN002755 Non-transformed cells respond to fat by inducing glucose metabolism Liver Mouse VIB-KU Leuven Center for Cancer Biology LC-MS
  logo